ArticleCancer chemotherapy and pharmacology2020

Variants of carboxylesterase 1 have no impact on capecitabine pharmacokinetics and toxicity in capecitabine plus oxaliplatin treated-colorectal cancer patients.

Natsumi Matsumoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.